CN1861183A - Traditional Chinese medicine capsule for treating mammary gland diseases - Google Patents
Traditional Chinese medicine capsule for treating mammary gland diseases Download PDFInfo
- Publication number
- CN1861183A CN1861183A CNA2006100176324A CN200610017632A CN1861183A CN 1861183 A CN1861183 A CN 1861183A CN A2006100176324 A CNA2006100176324 A CN A2006100176324A CN 200610017632 A CN200610017632 A CN 200610017632A CN 1861183 A CN1861183 A CN 1861183A
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicine
- mastopathy
- capsule
- mammary gland
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 10
- 239000003814 drug Substances 0.000 title abstract description 19
- 210000005075 mammary gland Anatomy 0.000 title description 4
- 201000010099 disease Diseases 0.000 title description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title description 3
- 208000030270 breast disease Diseases 0.000 claims abstract description 15
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 6
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 6
- 241000628997 Flos Species 0.000 claims description 5
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 5
- 241000195474 Sargassum Species 0.000 claims description 5
- 210000003038 endothelium Anatomy 0.000 claims description 5
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims 1
- 208000004396 mastitis Diseases 0.000 abstract description 7
- 210000000481 breast Anatomy 0.000 abstract description 4
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 241000234653 Cyperus Species 0.000 abstract 1
- 206010017553 Furuncle Diseases 0.000 abstract 1
- 206010060710 Galactostasis Diseases 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 229910052742 iron Inorganic materials 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010006298 Breast pain Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 208000006662 Mastodynia Diseases 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 235000021419 vinegar Nutrition 0.000 description 2
- 239000000052 vinegar Substances 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 1
- 206010006253 Breast fibrosis Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035752 proliferative phase Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000008448 thought Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 235000015099 wheat brans Nutrition 0.000 description 1
- 230000005186 women's health Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine in the form of capsule for treating mastopathy, such as mastoplasia, mammary duct obstruction, breast furuncle, acute mastitis, etc is prepared from 7 Chinese-medicinal materials including cyperus tuber, white peony root, safflower, notoginseng, etc.
Description
One, technical field
The present invention relates to a kind of Chinese medicinal capsule for the treatment of mastopathy.
Two, background technology
Mastopathy belongs to commonly encountered diseases in China, its coverage rate accounts for the 75%-85% of number of women, (comprising light, in, weigh three classes), along with extensively carrying out of whole society's cystic hyperplasia of breast generaI investigation, the widespread usage of science auxiliary detection means, the rate of finding of various mastopathy is improved.The trend that this mastopathy rises, numerous comrade's women health in serious threat.And the method and the medicine of existing treatment mastopathy, though also have a lot, comprise that not only Western medicine also comprises Chinese medicine, Western medicine can only relief of symptoms, but can not effect a permanent cure, though existing Chinese medicine also has certain effect, the course of treatment is long, and cure rate is not high, can only pain relieving, can not blood stasis dispelling, separate carbuncle, more can not cure, so mastopathy becomes difficult and complicated illness clinically.
Three, summary of the invention
The objective of the invention is to debate the improvement opinion, a kind of medicine for the treatment of mastopathy is provided according to the traditional Chinese medical science.Chinese medicine is thought, acute and chronic mastitis, and cyclomastopathy, breast tumor etc. belong to " acute mastitis " of the traditional Chinese medical science, the category of " nodules of the breast "; Breast caking, mastalgia are its two big cardinal symptoms, and stagnation of QI due to depression of the liver, the turbid mutual knot of expectorant, malicious evil pestilence knot then is the common pathologic basis of breast disease.So pharmaceutical formulation of the present invention is selected:
Rhizoma Cyperi 35-40 part, Radix Paeoniae Alba 35-45 part, Radix Bupleuri 40-50 part, Endothelium Corneum Gigeriae Galli 40-55 part, Radix Aucklandiae 30-35 part, Fructus Aurantii 20-25 part, Cornu Cervi 30-40 part, Cortex Magnoliae Officinalis 30-35 part, Radix Scrophulariae 20-30 part, Herba Taraxaci 30-50 part, Cortex Moutan 20-35 part, Thallus Laminariae (Thallus Eckloniae) 40-50 part, Spica Prunellae 20-30 part, Caulis Spatholobi 30-40 part, Flos Carthami 20-25 part, Radix Notoginseng 10-15 part, Poria 25-30 part, Sargassum 40-50 part, Fructus Amomi Rotundus 40-55 part.
The Radix Paeoniae Alba of the present invention, Fructus Aurantii, Rhizoma Cyperi, Cortex Magnoliae Officinalis, Endothelium Corneum Gigeriae Galli, Poria have blood circulation promoting and blood stasis dispelling, and depressed liver-energy dispersing and QI regulating is with the function of the pathogenic basis that disappears;
Sargassum, Thallus Laminariae (Thallus Eckloniae), Herba Taraxaci, Spica Prunellae have the eliminating stagnation carbuncle, and the effect of heat-clearing and toxic substances removing can be treated mastotic cardinal symptom;
Cortex Moutan, Flos Carthami, the Radix Aucklandiae, Caulis Spatholobi, Cornu Cervi, Radix Notoginseng, Radix Scrophulariae, Radix Bupleuri, Fructus Amomi Rotundus have the kidney invigorating essence, the yin nourishing removing heat from blood, and blood circulation promoting and blood stasis dispelling, suppressing the hyperactive liver and subsiding YANG, circulation of qi promoting are regulated the flow of vital energy, the effect of anti-inflammatory analgetic.
Theory of Chinese medical science thinks that all medicines are harmonious, and can reach the conditioning endocrine, suppressing the hyperactive liver the kidney invigorating, blood circulation promoting and blood stasis dispelling, detoxicating and resolving stagnation of pathogens, the effect of eliminating block and relieving pain.
Compounding method of the present invention is:
Select Rhizoma Cyperi, Radix Bupleuri, the Radix Aucklandiae, Endothelium Corneum Gigeriae Galli, the Fructus Aurantii of aforementioned proportion to soak 30 minutes with vinegar respectively, it is standby to pull airing out;
The Radix Paeoniae Alba of aforementioned proportion adds suitable vinegar with wheat bran and is placed in the iron pan slow fire and fried 15 minutes, and it is cool standby to dry in the air;
The Cornu Cervi of aforementioned proportion, Cortex Magnoliae Officinalis, Radix Scrophulariae, Herba Taraxaci, Cortex Moutan, Thallus Laminariae (Thallus Eckloniae), Spica Prunellae, Caulis Spatholobi, Flos Carthami, Radix Notoginseng, Poria, Sargassum, Fructus Amomi Rotundus are placed on respectively in the iron pan and fried 15 minutes with slow fire, and it is cool standby to dry in the air;
The medical material of the above-mentioned process of preparing Chinese medicine is put into oven for drying, and cooling is the powder powdered afterwards, incapsulates to get final product.
Good effect of the present invention is: short treating period, effect is fast, taking convenience, cheap, without any side effects, through clinic trial, the present invention is applicable to the state of an illness treatment in each stage of mastopathy, as the treatment of cyclomastopathy, newborn knot, acute mastitis, mastalgia, lactiferous ducts obstruction, the individual event of mammary gland fibrous tissue or multinomial proliferative phase.
Four, the specific embodiment
Get Rhizoma Cyperi 35g, Radix Paeoniae Alba 35g, Radix Bupleuri 45g, Endothelium Corneum Gigeriae Galli 55g, Radix Aucklandiae 35g, Fructus Aurantii 30g, Cornu Cervi 30g, Cortex Magnoliae Officinalis 30g, Radix Scrophulariae 20g, Herba Taraxaci 40g, Cortex Moutan 20g, Thallus Laminariae (Thallus Eckloniae) 40g, Spica Prunellae 30g, Caulis Spatholobi 35g, Flos Carthami 25g, Radix Notoginseng 10g, Poria 30g, Sargassum 45g, Fructus Amomi Rotundus 50g make capsule after concocting with preceding method, every heavy 0.25g.
Usage: oral;
Consumption: three times on the one, a 3-5 grain.
Withdraw menstrual period.
Use observation through 106 routine patients, 96 human oral Chinese medicinal capsule of the present invention wherein, 10 human antibiotics injections (transfusion); Cooperate the external application anti-inflammatory ointment.(three days change one time external application anti-inflammatory analgetic ointment).Cured 50 people in the capsular 2-3 of oral Chinese medicine days as a result; Cured 30 people in 3-7 days; Cured 10 people in 7-15 days; Cured 3 people in 16-20 days; Cured 2 people in 21-30 days; Cured 1 people in 30-35 days; Have and add external application medical ointment 10 people: cured in 3 people 15-25 days with antibiotics; Cured in 6 people 26-30 days; Also have people's DeGrain, result to make into again behind the oral Chinese medicine capsule to cure in 6 days.Contrast, Chinese medicinal capsule treatment mastopathy is better than the antibiotics effect, particularly newborn phase acute mastitis, the pain relieving in a day of oral this medicine, 3 days antiinflammatory knots.
Treatment mastopathy (individual event or the multinomial hypertrophy that comprise cyclomastopathy, acinus epithelium, glandular tube obstruction, lactiferous ducts fibrous tissue) is observed among the treatment 106 routine patients: 30 examples about 23 years old; 26-35 has 46 examples about year; 35-48 has 20 examples about year approximately.General about about about 3 centimetres * 3 centimetres of lump size, about 4 centimetres * about 5 centimetres, about 5 centimetres * about 6 centimetres; Also have lactiferous ducts to stop up slivering lock shape, hard as iron bar, be about about 3 centimetres, thick 3 millimeters, about long 3-4 centimetre, thick about 4 millimeter, etc. whole case histories of different signs all is by the making a definite diagnosis of sign inspection and far infrared mammary diagnosis instrument, and major part is one to stress, and opposite side is light slightly., about 25, have a bright and cheerful disposition for age bracket, take medicine on time, 70% acute mastitis, oral this medicine was taken a favourable turn in one day, pain relieving in two days, three days are cured.
Imitate slow for oral this medication, time length, accounting example about 30%, in clinical case, illness analysis, age bracket is at 40-50 about year, mastopathy has approximately and does not all obtain timely and effective treatment about 5-20, and the existence that majority contains several diseases of mammary gland is as (lobules of mammary gland bulk caking, lactiferous ducts strip stop up, hard as iron bar, breast fibrosis, hard as iron block etc.).Moreover the patient of this age bracket is intolerant mostly, can not take medicine on time fully.But the treatment through a period of time has also all reached desired therapeutic effect-recovery from illness.It is absolutely that medicine of the present invention is used effective percentage clinically.
Claims (1)
1, a kind of Chinese medicinal capsule for the treatment of mastopathy, it is characterized in that: it is by Rhizoma Cyperi 35-40 part, Radix Paeoniae Alba 35-45 part, Radix Bupleuri 40-50 part, Endothelium Corneum Gigeriae Galli 40-55 part, Radix Aucklandiae 30-35 part, Fructus Aurantii 20-25 part, Cornu Cervi 30-40 part, Cortex Magnoliae Officinalis 30-35 part, Radix Scrophulariae 20-30 part, Herba Taraxaci 30-50 part, Cortex Moutan 20-35 part, Thallus Laminariae (Thallus Eckloniae) 40-50 part, Spica Prunellae 20-30 part, Caulis Spatholobi 30-40 part, Flos Carthami 20-25 part, Radix Notoginseng 10-15 part, Poria 25-30 part, Sargassum 40-50 part, the capsule that Fructus Amomi Rotundus 40-55 part is made after pulverizing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100176324A CN100369626C (en) | 2006-04-04 | 2006-04-04 | Traditional Chinese medicine capsule for treating mammary gland diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100176324A CN100369626C (en) | 2006-04-04 | 2006-04-04 | Traditional Chinese medicine capsule for treating mammary gland diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1861183A true CN1861183A (en) | 2006-11-15 |
| CN100369626C CN100369626C (en) | 2008-02-20 |
Family
ID=37388769
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100176324A Expired - Fee Related CN100369626C (en) | 2006-04-04 | 2006-04-04 | Traditional Chinese medicine capsule for treating mammary gland diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100369626C (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101337048B (en) * | 2008-08-19 | 2010-12-08 | 姜雅平 | Medicine for treating hyperplasia of mammary glands |
| LT5701B (en) | 2010-03-29 | 2010-12-27 | VšĮ "Grunto valymo technologijos" | Phytochemical composition, method of preparation and use thereof |
| CN103585377A (en) * | 2013-10-18 | 2014-02-19 | 赵子山 | Oral medicine for treating breast nodules |
| CN105250576A (en) * | 2015-11-04 | 2016-01-20 | 安徽益健堂中药饮片科技有限公司 | Traditional Chinese medicine composition for treating mammary gland hyperplasia |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1201782C (en) * | 2002-11-29 | 2005-05-18 | 咸阳步长制药有限公司 | Medicine composition for treating mammary gland proliferation, and its prepn. method |
| CN1299736C (en) * | 2004-07-26 | 2007-02-14 | 耿新生 | Chinese medicine capsule for treating hyperplasia of mammary glands and its producing method |
-
2006
- 2006-04-04 CN CNB2006100176324A patent/CN100369626C/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101337048B (en) * | 2008-08-19 | 2010-12-08 | 姜雅平 | Medicine for treating hyperplasia of mammary glands |
| LT5701B (en) | 2010-03-29 | 2010-12-27 | VšĮ "Grunto valymo technologijos" | Phytochemical composition, method of preparation and use thereof |
| CN103585377A (en) * | 2013-10-18 | 2014-02-19 | 赵子山 | Oral medicine for treating breast nodules |
| CN105250576A (en) * | 2015-11-04 | 2016-01-20 | 安徽益健堂中药饮片科技有限公司 | Traditional Chinese medicine composition for treating mammary gland hyperplasia |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100369626C (en) | 2008-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111166861A (en) | Traditional Chinese medicine granules for treating novel coronavirus pneumonia, preparation method and transdermal patch | |
| CN101843656B (en) | External medicinal liquor for treating cancer and preparation method thereof | |
| CN106039271A (en) | Plaster for treating knee osteoarthritis | |
| CN100369626C (en) | Traditional Chinese medicine capsule for treating mammary gland diseases | |
| CN1899500A (en) | Acne clearing decoction | |
| CN1742979A (en) | Chinese medicine for treating proliferation of mammary gland | |
| CN1247086A (en) | Process for making medical wine for treating rheumatism | |
| CN1876157A (en) | A medicinal wine for treating rheumatic and rheumatoid disease | |
| CN1281228C (en) | Medicine for hyperplasia of mammary glands and its preparation | |
| CN1443545A (en) | Medicine for curing acne and its preparation method | |
| CN100404052C (en) | External use Chinese herbal medicine ointment for treating mammary cancer and lymph cancer | |
| CN1060078C (en) | Chinese herbal medicine composition for curing malignant lymphoma | |
| CN101337043B (en) | Traditional Chinese medicine for treating hyperplasia of mammary glands | |
| CN1709463A (en) | Medicament for treating traumatic diseases and preparation method thereof | |
| CN1301544A (en) | Medicinal composition for curing arthritis and osteoarthropathy and its preparing method | |
| CN1943764A (en) | The Chinese herbal medicinal pills for treatment of hepatitis B and liver cancer | |
| CN103690855A (en) | Traditional Chinese medicine composition for treating motility dysfunction-type dyspepsia | |
| CN101301412B (en) | Shuyu Sanjie Capsules | |
| CN1265810C (en) | A pharmaceutical composition for treating cyclomastopathy, and its preparation method | |
| CN101596255B (en) | Chinese medicament for preventing and curing leucemia | |
| CN1285369C (en) | Chinese medicine for treating gynopathy | |
| CN105663868A (en) | Traditional Chinese medicinal composition for treating aplastic anemia | |
| CN1965971A (en) | Externally applied compound medicinal tincture for treating intractable tinea and dermatitis and method for preparing same | |
| CN1958064A (en) | Chinese traditional medicine for external application of treating rheumatism like disease, preparation method and usage | |
| CN1261146C (en) | Plaster for treating hyperplasia of mammary glands |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080220 Termination date: 20120404 |